Oxford Sciences Innovation takes part in Oxstem's $24.4m round as it begins to develop pre-clinical small molecule drug candidates for its stem cell drugs.

Samsung made its second investment in the autonomous car software developer, taking part in a series A round that also included the Singaporean government.

Michigan University has backed a $4m series A round for ViewPoint, which is developing therapies for eye diseases.

UCL Business and the UCL Technology Fund have both contributed to a series A round for biotech company Orchard Therapeutics.

Australia-based data exchange platform Data Republic has raised $7.6m in a round featuring domestic corporates Qantas, Westpac and National Australia Bank.

Agenovir is commercialising technology developed at Stanford University and Howard Hughes Medical Institute that could eliminate currently untreatable viruses.

Samsung has led a $20.3m first funding round for Afero that also included SoftBank, Sumitomo, Sanshin Electronics and Infocom-backed Fenox.